Our company enables the simple, mobile use of highly effective cold plasma therapy in everyday medical practice and thus improves the quality of life of patients with chronic wounds.
Chronic wounds have a significant prevalence around the world, are a major cost factor in every healthcare system and they have a major impact on patients' quality of life
The Swiss company ActivCell Group AG has succeeded in integrating cold plasma technology into a compact wireless device, the ActivCellpen®, that facilitates the application of modern plasma medicine in daily practice.
The ActivCellpen® to date is the only cold plasma therapy device that combines maximum treatment flexibility due to its mobile design with the sustainability required in healthcare
Cold plasma per se has a number of beneficial effects on wound healing, first and foremost due to its antiseptic properties. It is effective against microorganisms, including multiresistant bacteria. Hence, the use of antibiotics can be reduced and cold plasma does not lead to resistance due to its physical properties. It thereby helps to tackle the global challenge of antibiotic resistance.
Through a combination of device sales and service agreements
Current set with initially one electrode 666 CHF
Planned selling price to distributor around 3000 CHF
The clusters on the previous page have a limited scope. The boxes to be ticked would be Healthcare / Medical Devices, and for the scope of this description, specifically the Wound Care market.
A combination of classical distribution channels (expanding the distributors' product portfolio with cold plasma therapy), strategic marketing partners (integrated care solutions, where cold plasma complements a therapeutic scheme) and direct online marketing .
ActivCell has succeeded in integrating cold plasma therapy into an easy to use, mobile device, which allows maximum treatment flexiblity while addressing sustainability needs in Healthcare.
The key functions are covered, but not by the original founders. ActivCell Group has been able to establish key functions and put a team in place, that is able to take the company into the future.
The three founders are all members of the board of the directors (consisting of a team of four), none of them has an operative function in the company
Provide financial key values of your startup. The turnover of the current year is mandatory.
Values in EUR thousand (TEUR)
Preferably, we are looking for equity financing, however we are open to other options, too.
An ideal investor would have an interest in the business beyond his ROI, would understand the challenges in a highly regulated environment such as the Medical Device industry and also Healthcare wrt to reimbursement schemes etc.